CRT 2026

HOT TOPICS IN CATHETER-DIRECTED TREATMENTS FOR PULMONARY EMBOLISM

Moderator(s)

• 

  Vikas Aggarwal, MD, MPH

  Director of venous and pulmonary vascular interventions
  Henry Ford Health System
  Ann Arbor, Michigan, United States

  Disclosure(s): No financial relationships to disclose
• 

  Rachel Rosovsky, MD, MPH

  Associate Professor, Harvard Medical school
  Massachusetts General Hospital
  Boston, Massachusetts, United States

  Disclosure(s): Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing); CSL: Consulting Fees (e.g., advisory boards) (Ongoing); Innova: Consulting Fees (e.g., advisory boards) (Ongoing); Inquis: Consulting Fees (e.g., advisory boards) (Ongoing); Penumbra, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

Panel Discussant(s)

• 

  George Chrysant, MD

  Chief Medical Officer
  INTEGRIS Cardiovascular Physicians, LLC
  Oklahoma City, Oklahoma, United States

  Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Acarix: Chief Medical Advisor (Ongoing); philips,shockwave,penumbra: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Amir Kaki, MD, FACC, FSCAI

  Director Mechanical Circulatory Support Director High-Risk Complex Coronary Interventions
  Henry Ford St John Hospital
  Birmingham, Michigan, United States

  Disclosure information not submitted.